- Home
- OCCI vs SCPH Comparison
OCCI vs SCPH Comparison
Compare OCCI & SCPH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- OCCI
- SCPH
- Stock Information
- Founded
- OCCI N/A
- SCPH 2013
- Country
- OCCI United States
- SCPH United States
- Employees
- OCCI N/A
- SCPH N/A
- Industry
- OCCI Trusts Except Educational Religious and Charitable
- SCPH Biotechnology: Pharmaceutical Preparations
- Sector
- OCCI Finance
- SCPH Health Care
- Exchange
- OCCI Nasdaq
- SCPH Nasdaq
- Market Cap
- OCCI 146.8M
- SCPH 173.6M
- IPO Year
- OCCI N/A
- SCPH 2017
- Fundamental
- Price
- OCCI $6.18
- SCPH $3.64
- Analyst Decision
- OCCI
- SCPH Strong Buy
- Analyst Count
- OCCI 0
- SCPH 3
- Target Price
- OCCI N/A
- SCPH $14.00
- AVG Volume (30 Days)
- OCCI 115.8K
- SCPH 423.8K
- Earning Date
- OCCI 12-11-2023
- SCPH 05-14-2025
- Dividend Yield
- OCCI 24.32%
- SCPH N/A
- EPS Growth
- OCCI N/A
- SCPH N/A
- EPS
- OCCI N/A
- SCPH N/A
- Revenue
- OCCI N/A
- SCPH $41,982,000.00
- Revenue This Year
- OCCI N/A
- SCPH $109.32
- Revenue Next Year
- OCCI $10.19
- SCPH $76.95
- P/E Ratio
- OCCI N/A
- SCPH N/A
- Revenue Growth
- OCCI N/A
- SCPH 138.10
- 52 Week Low
- OCCI $5.47
- SCPH $1.94
- 52 Week High
- OCCI $10.15
- SCPH $5.65
- Technical
- Relative Strength Index (RSI)
- OCCI 42.48
- SCPH 66.63
- Support Level
- OCCI $5.95
- SCPH $3.23
- Resistance Level
- OCCI $6.82
- SCPH $3.74
- Average True Range (ATR)
- OCCI 0.14
- SCPH 0.31
- MACD
- OCCI -0.06
- SCPH 0.08
- Stochastic Oscillator
- OCCI 28.09
- SCPH 93.81
About OCCI OFS Credit Company Inc.
OFS Credit Co Inc is a non-diversified, closed-end management investment company. Its investment objective is to generate current income, with a secondary objective to generate capital appreciation. The company invests in floating rate credit instruments and other structured credit investments, including; collateralized loan obligation (CLO) debt and subordinated (i.e., residual or equity) securities; traditional corporate credit investments, including leveraged loans and high yield bonds; opportunistic credit investments, including stressed and distressed credit situations and long/short credit investments; and other credit-related instruments.
About SCPH scPharmaceuticals Inc.
scPharmaceuticals Inc is a pharmaceutical company focused on developing and commercializing products that have the potential to optimize the delivery of infused therapies, advance patient care and reduce healthcare costs. The company's main product is Furoscix. Furoscix consists of this patented formulation of furosemide for subcutaneous administration with wearable, portable sc2Wear Infusor for the treatment of edema in patients with heart failure.